About Malecare

This author has not yet filled in any details.
So far Malecare has created 1663 blog entries.

Thanksgiving in USA – Thank You

I've been leading Malecare Cancer Support for nineteen years.  You have honored me by sharing your time, voice and heart in one or more of our programs.  Thank you for that! You have taught me a lot about happiness, disease, hurt and fear.  You've shown me respect, made me laugh, and challenged me when I was [...]

By | November 22nd, 2016|Uncategorized|0 Comments

“Do No Harm” NOT in Hippocratic Oath

I was talking to a prostate cancer patient about the difference between "harm" and "hurt," referring to the Hippocratic Oath.  Doctors are ok with "hurting" patients regarding impotence and incontinence, but do all they can to prevent "harm," or death.  Both of us agreed this distinction relates to the Hippocratic Oath.  But, turns out we [...]

By | November 15th, 2016|Uncategorized|0 Comments

Over 20,000 Have Pledged to Boycott CVS & Caremark until they sell Cancer Drugs Again- CVS removing many cancer drugs, including Xtandi, from it’s formulary

Sign pledge to boycott CVS here: CVS Pharmacy will hurt many cancer patients by removing dozens of cancer treatment drugs, like leukemia drug Tasigna, prostate cancer drug Xtandi and chemotherapy treatment drug Neupogen, from their formulary, starting in 2017. CVS claims these drugs cost too much. Go ahead and tell that to my insurance [...]

By | November 3rd, 2016|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

Prostate Cancer Podcast – Is Prostate Cancer Inherited?

Family history and genetics. Prostate cancer is often referred to as a family disease. Is it and what does this actually mean?   Malecare's Advanced Prostate Cancer Program Director, Joel Nowak, interviews Dr. Lorelei A. Mucci. Dr. Mucci is an epidemiologist specializing in prostate cancer. She works at the Harvard University School of Public Health in Boston, Massachusetts. [...]

By | May 13th, 2016|Advanced Prostate Cancer, Uncategorized|0 Comments

UPDATE: Malecare Advocacy Restores CDC Prostate Cancer Funding

UPDATE June 9, 2016 The Senate Appropriations Committee voted to approve its FY17 Labor-HHS Appropriations bill earlier today, with only one senator, Bill Cassidy (R-LA), voting against the bill. Funding for the Centers for Disease Control's Prostate Cancer activities program was restored!!! Thanks to all of Malecare's Patient Advocacy Leaders and ALL of You who [...]

By | March 28th, 2016|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

ZYTIGA – Potential Dosing Error – IMPORTANT

Error in ZYTIGA® Beginning Your Treatment Brochure It has come to Malecare's attention that the dosing schedule for ZYTIGA® (abiraterone acetate) is incorrectly described in the ZYTIGA® Beginning Your Treatment brochure. Please destroy the ZYTIGA® Beginning Your Treatment brochure and the ZYTIGA® Resource Kit. It contains inaccurate dosing information. Please ask your doctor, today, to ensure that you understand the appropriate dosing for ZYTIGA®. The recommended [...]

By | February 12th, 2016|Advanced Prostate Cancer, Uncategorized|4 Comments

Global Prostate Cancer Alliance

PROSTATE CANCER NETWORK Join here: A friendly, informal atmosphere where we can pick each other’s brains. Your 24 hour online support group. Talking about prostate cancer can be a powerful tool in learning to cope with it. Our community is run by the Prostate Cancer Network of the Global Prostate Cancer Alliance

By | February 9th, 2016|Newly Diagnosed|0 Comments

Global Prostate Cancer Alliance investigates why Black men in the UK die at twice the rate as White men.

The Global Prostate Cancer Alliance  requests your participation in a United Kingdom focused project regarding Prostate Cancer killing Black men at twice the rate as it does White descent.  We want to understand how Black men in the UK manage their disease while facing this massive disparity. First are telephone interviews with Black men diagnosed with prostate cancer [...]

Payment for PSA Prostate Cancer Screening may end

Believe it or not, in this week approaching Thanksgiving, we in the United States are faced with a second challenge to Prostate Cancer screening using the PSA test. Malecare wants you to know.   The Centers for Medicare and Medicaid Services (CMS) is asking for pubic comment on a clinical quality measure that would probably [...]

By | November 15th, 2015|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

USPSTF Responds to Malecare’s Questions regarding PSA Screening

Malecare sent questions to Albert Siu, MD, Chairperson of the U.S. Preventive Services Task Force about plans to review their 2012 recommendation against the use of the PSA test for prostate cancer screening.  We thought that this information would be important since the USPTF is currently soliciting public comments on the research design of their review [...]

By | November 11th, 2015|Advanced Prostate Cancer, Advocacy, PSA, Uncategorized, USPTF|0 Comments